• 2019 ANNUAL REPORT
    • CEO Letter
    • Board of Directors
    • Leadership Team
    • Stockholder Information
    • Proxy Statement
    • Form 10-K
    • Download 2019 Annual Report PDF
  • Patient Stories
    • Latarsha Jones
    • Stan Stanek
    • Chris Dougherty
    • Jasmin Watson-El
    • Yoshikazu Takahashi
  • PBRG
  • Environmental Stewardship
  • Development Portfolio
Menu
  • 2019 ANNUAL REPORT
    • CEO Letter
    • Board of Directors
    • Leadership Team
    • Stockholder Information
    • Proxy Statement
    • Form 10-K
    • Download 2019 Annual Report PDF
  • Patient Stories
    • Latarsha Jones
    • Stan Stanek
    • Chris Dougherty
    • Jasmin Watson-El
    • Yoshikazu Takahashi
  • PBRG
  • Environmental Stewardship
  • Development Portfolio
Latarsha Jones
Stan Stanek
Chris Dougherty
Jasmin Watson-El
Yoshikazu Takahashi

The patient stories shared in this Annual Report depict individual patient responses to our medicines or investigational compounds and are not representative of all patient responses. In addition, there is no guarantee that potential drugs or indications still in development will receive regulatory approval. This Annual Report contains statements about the company’s future plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Actual results may differ from those indicated as a result of various important factors, including those discussed in the company’s most recent annual report on Form 10-K and reports on Form 10-Q and Form 8-K. These documents are available from the SEC, the Bristol-Myers Squibb website or from Bristol-Myers Squibb Investor Relations. In addition, any forward-looking statements represent our estimates only as of the date hereof and should not be relied upon as representing our estimates as of any subsequent date. While we may elect to update forward-looking statements at some point in the future, we specifically disclaim any obligation to do so, even if our estimates change. This Annual Report also contains certain non-GAAP financial measures, adjusted to include certain costs, expenses, gains and losses and other specified items. Reconciliations of these non-GAAP financial measures to the most comparable GAAP measures are available on the company’s website at www.bms.com

Stan Stanek
Latarsha Jones
Chris Dougherty
Jasmin Watson-El
Yoshikazu Takahashi
bms_logo_rgb_pos_300

430 E. 29th Street, 14FL, New York, NY 10016 • 212-546-4000

2019 ANNUAL REPORT

  • CEO Letter
  • Development Pipeline
  • Achievements
  • Board of Directors
  • Leadership Team
  • Stockholder Information
  • Proxy Statement
  • Form 10-K
  • Download PDF

PATIENT STORIES

  • Latarsha Jones
  • Stan Stanek
  • Chris Dougherty
  • Jasmin Watson-El
  • Yoshikazu Takahashi

SPECIAL FEATURE

  • People and Business Resource Groups

© 2020 Bristol-Myers Squibb Company. All Rights Reserved.

Facebook
Twitter
Linkedin
Youtube